Candel Therapeutics (CADL) Other Operating Expenses (2024 - 2025)
Candel Therapeutics recorded quarterly Other Operating Expenses of $4.0 million in Q4 2025, down 5.2% quarter-over-quarter from $4.2 million in Q3 2025, and up 906.94% year-over-year from $392675.3 in Q4 2024.
Candel Therapeutics' Other Operating Expenses history runs 2 years deep, the most recent figure standing at $4.0 million for Q4 2025.
- In Q4 2025, Other Operating Expenses rose 906.94% year-over-year to $4.0 million; the TTM figure through Dec 2025 stood at $10.0 million (up 375.89% YoY), while the FY2025 annual figure was $13.9 million, up 808.61% from the prior year.
- Other Operating Expenses came in at $4.0 million for Q4 2025 at Candel Therapeutics, down from $4.2 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $4.2 million in Q3 2025 to a low of -$493000.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Candel Therapeutics | 449.62 Mn | 449.62 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.95 Mn |
| Sep 30, 2025 | 4.17 Mn |
| Jun 30, 2025 | -462,000.00 |
| Mar 31, 2025 | 2.31 Mn |
| Dec 31, 2024 | -490,000.00 |
| Sep 30, 2024 | -463,000.00 |
| Jun 30, 2024 | 3.54 Mn |
| Mar 31, 2024 | -493,000.00 |